特朗普承诺“大幅降低”Ozempic价格后诺和诺德、礼来公司股价下滑

Danish drugmaker Novo Nordisk (NVO) slipped 6% in early trading on Friday after U.S. President Donald Trump said on Thursday that the price of the company's top-selling weight-loss medication would be reduced.

Trump made the comments during a White House event on fertility treatments and drug pricing, as per reports.

He said the price of the blockbuster diabetes drug Ozempic could come down to just $150 a month, as per Bloomberg News.

The U.S. list price of Ozempic, which Trump called “the fat loss drug,” is roughly $1,000 for a month’s supply. Trump told reporters on Thursday that the cost of the drug, made by Novo, will soon be “much lower.”

Eli Lilly (LLY), which sells similar treatments, including Mounjaro and Zepbound, also ticked 4% lower.